NextBillion - An Initiative of the William Davidson Institute at the University of Michigan

Monday, September 26, 2016

• GlaxoSmithKline will discount the price of its pneumococcal vaccine to $3.05 per dose for charities which work to immunize refugees and displaced people. The price reduction for Synflorix is the first step in a broader pledge to supply essential vaccines to civil society organizations at lower prices.
• The British drugmaker had pledged earlier this year to provide Synflorix to Gavi, the Vaccine Alliance for the same $3.05 price per dose, which the company said would save $1 per child over the course of the vaccine.
• Médecins Sans Frontières (MSF), which has for years sharply criticized both GSK and Pfizer for keeping vaccine prices high, applauded the new, broader commitment as a “positive and critical step.” The humanitarian organization did, however, call on GSK to lower its vaccine prices in sales to governments of developing countries, in addition to aid groups.